Across TCGA pan-cancer cohorts, IFI30 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated IFI30 data layer compared with 21 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher IFI30 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated IFI30 expression acts as an unfavorable survival marker.

COAD and SKCM are the cancer types where IFI30 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.168	0.799	.004	12	view →
SKCM	OS	Median	All	0.395	0.784	.014	9	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: IFI30 tumor-vs-normal RNA expression · all IFI30 data types